- Latest week
- 17 Jul 2026
- Close
- 12.929300
- Fair value
- 10.116657
- Next-week expectancy
- Undecided 50.94%
BIOT Chart Pack
L&G Pharma Breakthrough UCITS ETF
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, BIOT rose 10.39%, moving from 11.71 to 12.93. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 5 of the last 12 weeks. Relative Strength is 1.74 and has softened across the 12-week window. Market Dynamics is 1.07 on the latest week. Next-week expectancy is undecided at 50.94% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 12.93
- 12-Week Change
- 10.39%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 50.94%
- Signal Weeks
- 5 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 1.74
- Market Dynamics
- 1.07
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 12.93
- 12-Week Change
- 10.39%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 50.94%
- Signal Weeks
- 5 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 1.74
- Market Dynamics
- 1.07
Over the latest 12 completed weeks ending 2026-07-17, BIOT rose 10.39%, moving from 11.71 to 12.93. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 5 of the last 12 weeks. Relative Strength is 1.74 and has softened across the 12-week window. Market Dynamics is 1.07 on the latest week. Next-week expectancy is undecided at 50.94% based on similar historical setup states.